{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-322859","form_type":"8-K","ticker":"STRO","cik":"0001382101","company_name":"SUTRO BIOPHARMA, INC.","filed_at":"2025-12-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.267673+00:00","generated_at":"2026-05-16T12:54:06.724893+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Sutro Biopharma regains Nasdaq minimum bid price compliance after prior deficiency","bullets":["Received Nasdaq notice on Dec 17, 2025 confirming compliance with Listing Rule 5450(a)(1) after 10 consecutive business days with closing bid at or above $1.00.","Non-compliance was initially disclosed on June 20, 2025 when bid price fell below $1.00 for 30 consecutive business days.","Listing matter is now closed; company meets all other Nasdaq Global Market continued listing criteria."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-322859","json":"https://secwatch.observer/filing/0001193125-25-322859.json","markdown":"https://secwatch.observer/filing/0001193125-25-322859.md","text":"https://secwatch.observer/filing/0001193125-25-322859.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382101/000119312525322859/0001193125-25-322859-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382101/000119312525322859/d40412d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T12:54:06.724893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}